ALS MODULE 7 Pharmacology Relates to HLT404C Apply Advanced Resuscitation Techniques
Introduction “There are no studies that addressed the order of drug administration. There is inadequate evidence to define the optimal timing or order for drug administration.” ARC Guideline 11.5 December 2010 page 2. The administration of drugs will almost certainly be used in cardiac arrests and should be prepared and given in accordance with the hospital guidelines and health care protocols whilst awaiting the orders and/or arrival of the doctor.
Introduction Drugs used in cardiac arrest can be
categorised according to therapeutic objectives. • To increase perfusion pressure and enhance contractility
e.g. Adrenaline • To correct arrhythmias e.g. Amiodarone • Restore electrolyte balance e.g. Magnesium, Potassium
Chloride, Calcium Chloride • To correct acidosis e.g. Sodium Bicarbonate
Specific Resuscitation Drugs Adrenaline Classification:
• Sympathomimetic Actions:
• Activates an adrenergic receptive mechanism on affected cells and imitates all actions of the sympathetic nervous system “Fight or Flight”
• Acts on both alpha and beta receptors and is the most potent alpha receptor activator causing peripheral vasoconstriction, increased heart rate & myocardial contractility
Specific Resuscitation Drugs Adrenaline Dosage:
• 10ml of 1:10,000 solution = 1 mg • 1ml of 1:1000 solution = 1mg
• add 9mls N/saline to make 1:10,000 • Can repeat every 3-5 minutes • No maximum dose
Method of Administration: • IV/IO/ETT
Specific Resuscitation Drugs Adrenaline Indications:
• Ventricular Fibrillation/pulseless Ventricular Tachycardia after initial counter shocks have failed (after 2nd shock then after every second cycle).
• Asystole and electromechanical dissociation (pulseless electrical activity) in initial cycle (then every second cycle).
• Relief of hypersensitivity reactions to drugs and other allergens – given either IM or SC
Specific Resuscitation Drugs Adrenaline Adverse effects:
• Tachyarrhythmias • Severe hypertension after resuscitation • Tissue necrosis if extravasation occurs • Other adverse effects such as arrhythmias,
headache and increase in myocardial oxygen demand
Specific Resuscitation Drugs Amiodarone Classification:
• Antiarrhythmic
Actions: • Suppresses SA node function • Decreases speed of conduction through AV node,
refractoriness of AV node • Prolongs PR, QRS and QT intervals • Increases the action potential of contractile fibres, e.g.
effects Na, K and Ca channels to slow the speed of conduction system
Amiodarone Dosage:
• 300mg Bolus • Additional bolus of 150mg could be considered • Maybe followed by an infusion – refer to local
protocols Method of Administration:
• Draw up gently/slowly to prevent froth • Slow push into either IV or IO
Specific Resuscitation Drugs
Specific Resuscitation Drugs Amiodarone Indications:
• Ventricular Fibrillation (VF) • Pulseless Ventricular Tachycardia (VT) • Conscious Ventricular Tachycardia - infusion • Rapid Atrial Fibrillation and Flutter - infusion
Specific Resuscitation Drugs Amiodarone Adverse effects:
• Hypotension • Bradycardia • Heart Block • Torsades de Pointes • GIT disturbances
This is why we give it as a SLOW PUSH
Specific Resuscitation Drugs Calcium Classification:
• Electrolyte
Actions: • Essential for normal muscle and nerve activity • It transiently increases myocardial excitability and
contractility and peripheral resistance. Dosage:
• 5-10mls of 10% calcium solution • Suggest dilute (20mls N/Saline) to minimise extravasation
effects. Please check your local protocols.
Specific Resuscitation Drugs Calcium Method of Administration:
• Slow push into either IV or IO Indications:
• Hyperkalaemia • Hypocalcaemia • Overdose of calcium channel blocking drugs
• e.g. Verapamil, Nifedipine
Specific Resuscitation Drugs Calcium Adverse effects:
• Increased myocardial and cerebral injury by mediating cell death
• Tissue necrosis with extravasation • Rapid IV administration causes flushing, burning
sensation and cardiac arrest
Specific Resuscitation Drugs Lignocaine Classification
• Antiarrhythmic Actions:
• Suppresses discharge from ectopic foci by blocking sodium channel, inhibits re-entry arrhythmias that lead to VT/VF
• Reduces action potential production which results in slowed cardiac conduction
Specific Resuscitation Drugs Lignocaine Dosage
• 1mg/kg body weight Bolus • Can give additional bolus of 0.5mg/kg
Method of Administration: • IV /IO/ETT
Indications • VF and pulseless VT where Amiodarone cannot be
used • Prophylaxis in the setting of recurrent VF or VT
Specific Resuscitation Drugs Lignocaine Adverse effects:
• Slurred speech • Altered consciousness • Muscle twitching • Seizures • Hypotension • Bradycardia • Heart block • Asystole
Specific Resuscitation Drugs Magnesium Classification:
• Electrolyte • Antiarrhythmic
Actions: • Magnesium is an electrolyte essential for membrane stability. • Hypomagnesaemia causes myocardial hyperexcitability
particularly in the presence of hypokalaemia and digoxin. • Anticonvulsant
Specific Resuscitation Drugs Magnesium Dosage:
• Bolus of 5mmol. • Suggest dilute (20mls N/Saline) to minimise extravasation
effects. • Infusion (20mmols over 4 hour) Please check your local
protocols
Method of Administration: • Slow push into either IV or IO • Infusion
Specific Resuscitation Drugs Magnesium Indications:
• Torsades de Pointes • VF/pulseless VT (usually administered when
refractory to defibrillator shocks and a vasopressor) • Known hypokalaemia • Known hypomagnesium • Cardiac arrest from Digoxin toxicity
Specific Resuscitation Drugs Magnesium Adverse Effects:
• Hypotension • Bradyarrhythmia • Respiratory failure • Muscle weakness • Flushing
Specific Resuscitation Drugs Potassium Chloride Classification:
• Electrolyte Actions:
• Potassium is an electrolyte essential for membrane stability.
• Low serum potassium, especially in conjunction with digoxin therapy and hypomagnesaemia, may lead to life threatening ventricular arrhythmias.
Specific Resuscitation Drugs Potassium Chloride Dosage:
• Bolus of 5mmol • Suggest dilute (20mls N/Saline) to minimise extravasation
effects. Please check your local protocols
Method of Administration: • Slow push into either IV or IO
Indications: • Persistent VF due to documented or suspected
hypokalaemia
Specific Resuscitation Drugs Sodium Bicarbonate
• Use only with adequate ventilation and CPR • Consider if arrest is over 15 minutes or in known
metabolic acidosis - take an ABG/VBG for pH if no return of spontaneous circulation (ROSC)
• Prolonged arrest can result in lactic acid build up (acidosis), which can lead to depression of cardiac contractility.
Specific Resuscitation Drugs Sodium Bicarbonate Dosage:
• 1mmol/kg infused over 2-3 minutes then guided by ABG’s or VBG’s
Adverse Effects: • Metabolic alkalosis, hypokalaemia, hypernatraemia
and hyperosmolality. • Sodium bicarbonate and adrenaline or calcium
when mixed together may inactivate each other, precipitate and block the IV line.
Specific Resuscitation Drugs Atropine Classification:
• Anticholinergic Actions:
• Parasympathetic antagonist that accelerates sinus or atrial pacemakers
• Increases atrioventricular conduction • Increases heart rate, • Conduction & cardiac output
Specific Resuscitation Drugs Atropine Dosage:
• 600mcg – 1mg • Repeated as necessary every 3-5 min up to a total dose of 3 mg
Method of Administration: • IV/IO/ETT
Indications: • Symptomatic bradycardia (see guideline 11.9): -
• systolic BP < 90 mmHg • heart rate < 40/min • ventricular arrhythmia • heart failure
Specific Resuscitation Drugs Atropine Adverse effects:
• Tachycardia • Rebound bradycardia if given too slowly or dose too
small • Blurred Vision • Delirium • Hyperthermia in large doses
Summary Asystole – Adrenaline
VT/VF - Defibrillation +/- Amiodarone
Hyperkalaemic arrest – Bicarbonate and Calcium
Electrolytes – Known/suspected U+E’s imbalance
Protracted arrest/acidosis - Sodium Bicarbonate
Bradycardia - Atropine
ALL FLUSHED WITH 20 - 30MLS OF NORMAL SALINE
http://www.eremotelearning.com.au/moodle/file.php/11/ALS_Flowchart_Adults.pdf
To view PDF file, Click Here
Pharmacology Further Reading/Resources
• ARC Guidelines December 2010 – Guideline 11.5 and 11.9 www.resus.org.au
• Australian Injectable Drug Handbook, 4th Edition 2009, SHPA
• Australian Medicines Handbook 2009 • Rapid ACLS, Barbara Aehlert, RN. Mosby Inc 2007 • The Merck Manual Online Medical Library, http://
www.merck.com/mmpe/index.html
Pharmacology Next Steps Please now complete the online quiz by clicking on the exit button - top right hand of your screen. This will take you back to the Topic Outline page. Scroll down to 7 - Module Assessment and complete the online Final Assessment. Please complete the Evaluation form and print off your certificate.